Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4161-4166

  Kudoh, K ^a   Ramanna, M ^a   Ravatn, R ^a   Elkahloun, A G ^a   Bittner, M L ^a   Meltzer, P S ^a   Trent, J M ^a   Dalton, W S ^a   Chin, K V ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOXORUBICIN;

ARTICLE; CANCER CELL; DNA DETERMINATION; DNA HYBRIDIZATION; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MONITORING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DNA, COMPLEMENTARY; DNA, NEOPLASM; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0033891762     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Function and regulation of the human multidrug resistance gene
2. P-glycoprotein and multidrug resistance
3. Biology of the multidrug resistance-associated protein, MRP
4. DNA repair: Enzymatic mechanisms and relevance to drug response
5. Role of oncogenes in resistance and killing by cancer therapeutic agents
6. Light directed spatially addressable parallel chemical synthesis
7. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization
8. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes
9. Use of a cDNA microarray to analyze gene expression patterns in human cancer
10. Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
11. Expression monitoring by hybridization to high-density oligonucleotide arrays
12. Exploring the metabolic and genetic control of gene expression on a genomic scale
13. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors
14. A genome-wide transcriptional analysis of the mitotic cell cycle
15. The transcriptional program of sporulation in budding yeast
16. Drug target validation and identification of secondary drug target effects using DNA microarrays
17. The transcriptional program in the response of human fibroblasts to serum
18. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF-7 human breast cancer cell line
19. The Dr1/DRAPI heterodimer is a global repressor of transcription in vivo
20. The proteasome: Paradigm of a self-compartmentalizing protease
21. Resistance to diverse drugs and ultraviolet light conferred by overexpression of a novel human 26 S proteasome subunit
22. The ubiquitin-proteasome pathway in cancer
23. Induction of differentiation and growth arrest associated with nascent (nonoligosomal) DNA fragmentation and reduced c-myc expression in MCF-7 human breast tumor cells after continuous exposure to a sublethal concentration of doxorubicin
24. Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked
25. Bcl-2 family proteins
26. Schedule-dependent synergism of combinations of hydroxyurea with adriamycin and 1-β-D-arabinofuranosylcytosine with adriamycin
27. Expression of xenobiotic metabolizing enzymes in breast cancer
28. The expression of cytochrome P-450, epoxide hydrolase, and glutathione S-transferase in hepatocellular carcinoma
29. The proteasome
30. Solution structure of the single-strand break repair protein XRCC1 N-terminal domain